Search from 1166 projects:
An open-label, multicenter, randomized Phase 2 study of the ATR inhibitor tuvusertib in combination with the PARP inhibitor niraparib or the ATM inhibitor lartesertib in participants with BRCA mutant and/or homologous recombination deficiency (HRD) p...
Clinical Studies - Sep 30, 2024 - Sep 30, 2028
Ongoing
Project leader: Huober Jens Members: Dei Cas Alissa, Müller Fiona
MATAO- MAintenance Therapie mit Aromatasehemmer (Letrozol) für Patientinnen mit epithelialem Ovarialkarzinom: Eine randomisierte doppel-blinde Placebo-kontrollierte Phase III Studie inklusive LOGOS (LOw Grade Ovarian cancer Sub-study) (ENGOT-ov54/S...
Clinical Studies - Jul 18, 2019 - Dec 31, 2025
Project leader: Hornung René Members: Baldinger Jeannette, Kozlova Aleksandra
We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy
